14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $11.42 $11.42 Wednesday, 17th Aug 2022 VTL stock ended at $11.42. During the day the stock fluctuated 0% from a day low at $11.42 to a day high of $11.42.
90 days $11.42 $11.42
52 weeks $6.96 $14.50

Historical Vital Therapies prices

Date Open High Low Close Volume
Jan 29, 2016 $8.66 $9.23 $8.25 $9.15 150 700
Jan 28, 2016 $8.99 $9.03 $8.40 $8.60 173 100
Jan 27, 2016 $8.83 $9.02 $8.60 $8.76 142 900
Jan 26, 2016 $8.82 $8.90 $8.47 $8.80 96 100
Jan 25, 2016 $8.55 $8.95 $8.50 $8.67 159 800
Jan 22, 2016 $8.51 $8.82 $8.31 $8.57 205 900
Jan 21, 2016 $8.20 $8.50 $7.91 $8.26 162 900
Jan 20, 2016 $8.22 $8.44 $7.81 $8.18 310 300
Jan 19, 2016 $8.59 $8.90 $8.08 $8.40 247 800
Jan 15, 2016 $8.36 $8.71 $8.04 $8.67 210 900
Jan 14, 2016 $8.31 $8.85 $7.98 $8.64 167 100
Jan 13, 2016 $8.90 $9.13 $8.27 $8.40 142 100
Jan 12, 2016 $8.55 $9.09 $8.15 $8.88 212 500
Jan 11, 2016 $8.92 $8.94 $8.10 $8.62 231 700
Jan 08, 2016 $9.03 $9.56 $8.80 $8.86 226 500
Jan 07, 2016 $9.40 $9.40 $8.79 $8.97 279 600
Jan 06, 2016 $10.07 $10.07 $9.40 $9.61 376 700
Jan 05, 2016 $10.52 $10.64 $10.05 $10.20 234 200
Click to get the best stock tips daily for free!

About Vital Therapies

Vital Therapies, Inc., a biotherapeutic company, focuses on developing a cell-based therapy for the treatment of acute liver failure in the United States. Its ELAD system is an extracorporeal human allogeneic cellular liver that is in Phase III clinical trials to allow the patient’s own liver to regenerate to a healthy state, or to stabilize the patient until transplant. The company was formerly known as Vitagen Acquisition Corp. and changed its... VTL Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT